SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001855763-22-000011
Filing Date
2022-09-06
Accepted
2022-09-06 12:48:40
Documents
1
Period of Report
2022-09-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1428
  Complete submission text file 0001855763-22-000011.txt   2939
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19900 MACARTHUR BLVD., SUITE 550 IRVINE CA 92612
Business Address
TURKEL CATHERINE C. (Reporting) CIK: 0001705278 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39874 | Film No.: 221227724